XJPX
4078
Market cap382mUSD
Jul 10, Last price
4,115.00JPY
1D
1.48%
1Q
12.28%
Jan 2017
110.49%
Name
Sakai Chemical Industry Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sakai Chemical Industry Co., Ltd., a Japanese enterprise, manufactures and distributes a broad spectrum of chemical products. Its extensive portfolio encompasses titanium dioxide, employed in diverse applications including paints, printer inks, paper manufacturing, plastics, synthetic fibers, rubber, and porcelain enamel, as well as in optical lenses and capacitors. The company also supplies barium and strontium compounds, vital for electronic materials, various paints, inks, plastics, glass, and cosmetic formulations. Zinc-based offerings include zinc oxide, widely used in rubber, paints, plastics, electronics, and cosmetics, alongside zinc dust for anti-corrosion paints. Furthermore, Sakai Chemical provides plastic additives like stabilizers, lubricants, light stabilizers, and flame retardants, integrated into products such as pipes, electrical wires, industrial films, and wallpapers. Its specialized products extend to various catalysts, including De-NOx/De-DXN, hydrogenation, ozone decomposition, polyester polymerization, and photocatalysts. The company also produces electronic materials, specifically dielectric and piezoelectric ceramics. In the pharmaceutical domain, it offers prescription and over-the-counter drugs, health foods, active pharmaceutical ingredients, and intermediates. Rounding out its offerings are organic chemical products for sectors like electronics, resin materials, healthcare, lubricants, and water treatment, as well as road marking materials crucial for traffic management and safety. Founded in 1918, Sakai Chemical Industry Co., Ltd. is headquartered in Sakai, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||